{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:48:05Z","timestamp":1791582485651,"version":"4.3.4"},"reference-count":70,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01347","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T04:14:03Z","timestamp":1508386443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins"],"prefix":"10.3389","volume":"8","author":[{"given":"Adrien","family":"Bosseboeuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Allain-Maillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mennesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Garderet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Caillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Piver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Girodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Brouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Nicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Bigot-Corbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Hermouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1182\/blood-2008-07-167569","article-title":"Hepatitis C virus (HCV) infection, monoclonal immunoglobulin specific for HCV core protein, and plasma-cell malignancy","volume":"112","author":"Bigot-Corbel","year":"2008","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1056\/NEJM200301093480219","article-title":"Hepatitis C virus, human herpesvirus 8, and the development of plasma-cell leukemia","volume":"348","author":"Hermouet","year":"2003","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1046\/j.1365-2141.2002.03912.x","article-title":"Helicobacter pylori infection and monoclonal gammopathy of undetermined significance","volume":"119","author":"Rajkumar","year":"2002","journal-title":"Br J Haematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1158\/1078-0432.CCR-10-2578","article-title":"Epstein-barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes","volume":"17","author":"Saha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: a systematic review","volume":"85","author":"Wadhera","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"145293","DOI":"10.1155\/2015\/145293","article-title":"Pathogenesis of myeloproliferative neoplasms: role and mechanisms of chronic inflammation","volume":"2015","author":"Hermouet","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/cancers6031631","article-title":"The hepatocyte growth factor (HGF)\/met axis: a neglected target in the treatment of chronic myeloproliferative neoplasms?","volume":"6","author":"Boissinot","year":"2014","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e95367","DOI":"10.1172\/jci.insight.95367","article-title":"Monoclonal IgG in MGUS and multiple myeloma target infectious pathogens","volume":"2","author":"Bosseboeuf","year":"2017","journal-title":"JCI Insight"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1235681","DOI":"10.1126\/science.1235681","article-title":"Emerging principles for the therapeutic exploitation of glycosylation","volume":"343","author":"Dalziel","year":"2014","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(88)91781-3","article-title":"Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity","volume":"1","author":"Parekh","year":"1988","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0896-8411(91)90173-A","article-title":"Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy","volume":"4","author":"Rook","year":"1991","journal-title":"J Autoimmun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1186\/ar2892","article-title":"Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study","volume":"11","author":"van de Geijn","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19571","DOI":"10.1073\/pnas.0810163105","article-title":"Identification of a receptor required for the anti-inflammatory activity of IVIG","volume":"105","author":"Anthony","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/eji.201142260","article-title":"IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1","volume":"42","author":"Schwab","year":"2012","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00281-006-0052-1","article-title":"Activating and inhibitory FcgammaRs in autoimmune disorders","volume":"28","author":"Nimmerjahn","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.molimm.2006.09.005","article-title":"Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality","volume":"44","author":"Scallon","year":"2007","journal-title":"Mol Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/eji.201344230","article-title":"Broad requirement for terminal sialic acid residues and Fc\u03b3RIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo","volume":"44","author":"Schwab","year":"2014","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1749-6632.2011.06305.x","article-title":"Novel roles for the IgG Fc glycan","volume":"1253","author":"Anthony","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1172\/JCI82695","article-title":"Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity","volume":"125","author":"Quast","year":"2015","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/6179","article-title":"Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity","volume":"17","author":"Uma\u00f1a","year":"1999","journal-title":"Nat Biotechnol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.molimm.2012.01.001","article-title":"An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab","volume":"50","author":"Gasdaska","year":"2012","journal-title":"Mol Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jaci.2012.02.037","article-title":"Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs","volume":"129","author":"Oefner","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1172\/JCI65938.tosylated","article-title":"T cell \u2013 independent B cell activation induces immunosuppressive sialylated IgG antibodies","volume":"123","author":"Hess","year":"2013","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1073\/pnas.1523968113","article-title":"B-cell-independent sialylation of IgG","volume":"113","author":"Jones","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jcp.51.11.825","article-title":"Increased sialylation of oligosaccharides on IgG paraproteins \u2013 a potential new tumour marker in multiple myeloma","volume":"51","author":"Fleming","year":"1998","journal-title":"J Clin Pathol"},{"key":"B37","first-page":"5345","article-title":"Carbohydrate analysis of immunoglobulin G myeloma proteins by lectin and high performance liquid chromatography: role of glycosyltransferases in the structures","volume":"50","author":"Nishiura","year":"1990","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1021\/acs.jproteome.6b00768","article-title":"Polyclonal immunoglobulin G N -glycosylation in the pathogenesis of plasma cell disorders","volume":"16","author":"Mittermayr","year":"2017","journal-title":"J Proteome Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ab.2012.10.012","article-title":"Multiplexed infectious protein microarray immunoassay suitable for the study of the specificity of monoclonal immunoglobulins","volume":"433","author":"Feron","year":"2013","journal-title":"Anal Biochem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.humimm.2015.10.021","article-title":"Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection","volume":"77","author":"Malard-Castagnet","year":"2016","journal-title":"Hum Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1749-6632.1973.tb47530.x","article-title":"Microheterogeneity and allomorphism of proteins","volume":"209","author":"Williamson","year":"1973","journal-title":"Ann N Y Acad Sci"},{"key":"B42","first-page":"123","article-title":"Isoelectric focusing, blotting and probing methods for detection and identification of monoclonal proteins","volume":"30","author":"Cornell","year":"2009","journal-title":"Clin Biochem Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"M111.009001","DOI":"10.1074\/mcp.M111.009001","article-title":"Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells","volume":"10","author":"Nakano","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/cas.12627","article-title":"Increased sialidase activity in serum of cancer patients: identification of sialidase and inhibitor activities in human serum","volume":"106","author":"Hata","year":"2015","journal-title":"Cancer Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1002\/pmic.200800248","article-title":"Human sialidase as a cancer marker","volume":"8","author":"Miyagi","year":"2008","journal-title":"Proteomics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1681\/ASN.2015010109","article-title":"Glycosylation profile of IgG in moderate kidney dysfunction","volume":"27","author":"Barrios","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1016\/j.jmb.2014.07.006","article-title":"Structural characterization of anti-inflammatory immunoglobulin G Fc proteins","volume":"426","author":"Ahmed","year":"2014","journal-title":"J Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"9868","DOI":"10.1073\/pnas.1307864110","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B51","doi-asserted-by":"publisher","first-page":"E2385","DOI":"10.1073\/pnas.1505292112","article-title":"Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs","volume":"112","author":"Fiebiger","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bjh.12146","article-title":"Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease","volume":"160","author":"Musolino","year":"2013","journal-title":"Br J Haematol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e58504","DOI":"10.1371\/journal.pone.0058504","article-title":"The systemic cytokine environment is permanently altered in multiple myeloma","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"518","DOI":"10.7150\/jca.9266","article-title":"HGF, sIL-6R and TGF-\u03b21 play a significant role in the progression of multiple myeloma","volume":"5","author":"Jurczyszyn","year":"2014","journal-title":"J Cancer"},{"key":"B55","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V91.3.806","article-title":"Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group","volume":"91","author":"Seidel","year":"1998","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1158\/1078-0432.CCR-13-2442","article-title":"Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B57","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1182\/blood.V94.11.3883","article-title":"Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease","volume":"94","author":"Hjertner","year":"1999","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1046\/j.1445-5994.2001.00055.x","article-title":"Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance","volume":"31","author":"Diamond","year":"2001","journal-title":"Intern Med J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","article-title":"Role of transforming growth factor-beta in hematologic malignancies","volume":"107","author":"Dong","year":"2006","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.exphem.2006.06.017","article-title":"Chemokines in multiple myeloma","volume":"34","author":"Aggarwal","year":"2006","journal-title":"Exp Hematol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2141.2004.04864.x","article-title":"Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1\u03b1 and MIP-1\u03b2 correlates with lytic bone lesions in patients with multiple myeloma","volume":"125","author":"Hashimoto","year":"2004","journal-title":"Br J Haematol"},{"key":"B62","first-page":"3111","article-title":"Prognostic value of bone marrow angiogenesis in multiple myeloma","volume":"6","author":"Rajkumar","year":"2000","journal-title":"Clin Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s002770000236","article-title":"Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma","volume":"79","author":"Sezer","year":"2000","journal-title":"Ann Hematol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2007-10-116590","article-title":"Validation of PDGFRbeta and c-Src tyrosine kinases as tumor\/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib","volume":"112","author":"Coluccia","year":"2008","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ni.3579","article-title":"Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease","volume":"18","author":"Pfeifle","year":"2016","journal-title":"Nat Immunol"},{"key":"B66","first-page":"19840","article-title":"Leptin and its receptor in hematologic malignancies","volume":"8","author":"Han","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B67","first-page":"241","article-title":"Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics","volume":"28","author":"Pamuk","year":"2006","journal-title":"Exp Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1600-0609.2009.01311.x","article-title":"Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma","volume":"83","author":"Reseland","year":"2009","journal-title":"Eur J Haematol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/biof.1339","article-title":"Cytokine and adipokine are biofactors can act in blood and colostrum of obese mothers","volume":"43","author":"Fujimori","year":"2017","journal-title":"Biofactors"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1005460","DOI":"10.1080\/2162402X.2015.1005460","article-title":"Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival","volume":"4","author":"Di Lullo","year":"2015","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01347\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T03:39:04Z","timestamp":1603165144000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01347\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2017.01347"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01347","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]},"article-number":"1347"}}